Dr sc. Ivana Tadić

Dr sc. Ivana Tadić

Zvanje: vanredni profesor
Organizaciona jedinica: Katedra za socijalnu farmaciju i farmaceutsko zakonodavstvo
Prostorija: Kancelarija Centra za razvoj farmaceutske i biohemijske prakse
Telefon: +381 11 3951-206
Email: ivana.tadic@pharmacy.bg.ac.rs

CV


Prof. dr sci. Ivana Tadić je vanredni profesor koji izvodi nastavu iz više predmeta: Farmaceutska praksa, Farmakoepidemiologija i farmakoekonomija, Farmaceutski marketing, Primena informatičkih metoda u farmaciji i Interprofesionalno obrazovanje. Nakon završenih osnovnih studija radila je kao farmaceut u apoteci. Završila je doktorske studije, program Socijalna farmacija i istraživanje farmaceutske prakse, na Farmaceutskom fakultetu Univerziteta u Beogradu. Usavršavala se i iz oblasti Farmaceutski marketing i Farmakoekonomija i farmaceutska legislativa u okviru specijalističkih akademskih studija na istom fakultetu. Aktivno učestvuje u više domaćih i međunarodnih organizacija, kao i više domaćih i međunarodnih projekata. Pored ostalih akademskih aktivnosti rukovodilac je i Centra za razvoj farmaceutske i biohemijske prakse na Farmaceutskom fakultetu Univerziteta u Beogradu.

Njeni primarni istraživački interesi su: istraživanje zdravstvenih ishoda, farmakoekonomija, analiza pružanja farmaceutskih usluga.

  • Novak H, Tadić I, Falamić S, Ortner Hadžiabdić M. J Pharmacists' role, work practices, and safety measures against COVID-19: A comparative study. Am Pharm Assoc (2003). 2021;61(4):398-407. doi: 10.1016/j.japh.2021.03.006.
  • Turcu-Stiolica A, Kamusheva M, Bogdan M, Tadic I, Harasani K, Subtirelu MS, Meca AD, Šesto S, Odalović M, Arsić J, Stojkov S, Terzieva E, Petrova G. Pharmacist's Perspectives on Administering a COVID-19 Vaccine in Community Pharmacies in Four Balkan Countries. Front Public Health. 2021;9:766146. doi: 10.3389/fpubh.2021.766146.
  • Riad A, Schünemann H, Attia S, Peričić TP, Žuljević MF, Jürisson M, Kalda R, Lang K, Morankar S, Yesuf EA, Mekhemar M, Danso-Appiah A, Sofi-Mahmudi A, Pérez-Gaxiola G, Dziedzic A, Apóstolo J, Cardoso D, Marc J, Moreno-Casbas M, Wiysonge CS, Qaseem A, Gryschek A, Tadić I, Hussain S, Khan MA, Klugarova J, Pokorna A, Koščík M, Klugar M. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects. Int J Environ Res Public Health. 2021;18(15):7859. doi: 10.3390/ijerph18157859.
  • Michel DE, Iqbal A, Faehrmann L, Tadić I, Paulino E, Chen TF, Moullin JC. Using an online nominal group technique to determine key implementation factors for COVID-19 vaccination programmes in community pharmacies. Int J Clin Pharm. 2021;43(6):1705-1717. doi: 10.1007/s11096-021-01335-x.
  • Pavlov-Dolijanovic S, Vujasinovic Stupar N, Zugic V, Ostojic P, Zekovic A, Zivanovic Radnic T, Jeremic I, Tadic I. Long-term effects of immunosuppressive therapy on lung function in scleroderma patients. Clin Rheumatol. 2018;37(11):3043-3050. doi: 10.1007/s10067-018-4266-0.
  • Costa FA, Scullin C, Al-Taani G, Hawwa AF, Anderson C, Bezverhni Z, Binakaj Z, Cordina M, Foulon V, Garcia de Bikuña B, de Gier H, Granås AG, Grinstova O, Griese-Mammen N, Grincevicius J, Grinceviciene S, Kaae S, Kubiliene L, Mariño EL, Martins S, Modamio P, Nadin G, Nørgaard LS, Obarcanin E, Tadic I, Tasic L, McElnay JC, Hersberger KE, Westerlund T. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading? J Eval Clin Pract. 2017;23(6):1336-47. doi: 10.1111/jep.12783
  • Tadic I, Vujasinovic Stupar N, Tasic L, Stevanovic D, Dimic A, Stamenkovic B, Stojanovic S, Milenkovic S. Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Srbijan population. Health Qual Life Outcomes 2012;10:74.
  • Lakić D, Stević I, Odalović M, Vezmar-Kovačević S, Tadić I. Patients' willingness to pay for cognitive pharmacist services in community pharmacies. Croat Med J. 2017;58(5):364-371. doi: 10.3325/cmj.2017.58.364.
  • Crnjanski T, Krajnovic D, Tadic I, Stojkov S, Savic M. An Ethical Issue Scale for Community Pharmacy Setting (EISP): Development and Validation. Sci Eng Ethics. 2016;22(2):497-508. doi: 10.1007/s11948-014-9587-z. 2
  • Stojkov S, Tadić I, Crnjanski T, Krajnović D. Assessment and self-assessment of the pharmacists' competencies using the global competency framework (GbCF) in Srbija. Vojnosanit Pregl. 2016 Sep;73(9):803-10. doi: 10.2298/VSP140728040S.